🇺🇸 FDA
Patent

US 7560263

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

granted A61KA61K38/164A61K38/51

Quick answer

US patent 7560263 (Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K38/164, A61K38/51, A61P, A61P1/04